Subsidiary of Fuan Pharmaceutical (300194.SZ) receives registration certificate for Zolmitriptan Hydrochloride Tablets.
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical") recently received the drug registration certificate for Quetiapine Hydrochloride Tablets issued by the National Medical Products Administration. Quetiapine hydrochloride tablets are used to treat depression and are effective for patients with or without anxiety.
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical"), recently received the drug registration certificate for Quetiapine hydrochloride tablets issued by the National Medical Products Administration. Quetiapine hydrochloride tablets are used for the treatment of depression and are effective for patients with or without anxiety.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


